News & Events
29 June 2024
PREFERABLE at the MASCC Annual Meeting
We are thrilled to announce that our final conference will take place on June 29th, as part of the MASCC Annual Meeting in Lille!
8 January 2024
Following the San Antonio Breast Cancer Symposium, the ASCO post has written a nice article on the results of the Preferable project: Patients With Advanced Breast Cancer May Gain Multiple Benefits From Exercise as Part of Palliative Care
7 December 2023
PREFERABLE at the San Antonio Breast Cancer Symposium (SABCS) - first official presentation of results
The first results from the PREFERABLE-EFFECT trial were unveiled at the San Antonio Breast Cancer Symposium (SABCS), held December 5-9, 2023.

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.